The Cooper Cos. (NYSE:COO) shares hit a new 52-week high during mid-day trading on Friday . The stock traded as high as $183.86 and last traded at $182.67, with a volume of 51,301 shares. The stock had previously closed at $181.77.

COO has been the subject of several research analyst reports. Jefferies Group upgraded shares of The Cooper Cos. from a “hold” rating to a “buy” rating and set a $175.00 price target for the company in a report on Friday, April 15th. Robert W. Baird reiterated a “buy” rating on shares of The Cooper Cos. in a report on Tuesday, April 19th. Cleveland Research upgraded shares of The Cooper Cos. from a “neutral” rating to a “buy” rating in a report on Monday, May 16th. Wells Fargo & Co. reiterated a “hold” rating on shares of The Cooper Cos. in a report on Friday, June 3rd. Finally, Piper Jaffray Cos. reiterated a “buy” rating on shares of The Cooper Cos. in a report on Saturday, June 4th. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus target price of $167.00.

The stock has a market cap of $8.86 billion and a price-to-earnings ratio of 43.26. The company’s 50 day moving average price is $175.07 and its 200 day moving average price is $156.04.

The Cooper Cos. (NYSE:COO) last posted its quarterly earnings data on Thursday, June 2nd. The medical device company reported $2.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.91 by $0.14. During the same period in the prior year, the company earned $1.72 earnings per share. The company had revenue of $484.80 million for the quarter. The business’s revenue was up 11.5% compared to the same quarter last year. Equities analysts expect that The Cooper Cos. will post $8.40 EPS for the current fiscal year.

The business also recently disclosed a semiannual dividend, which will be paid on Friday, August 5th. Stockholders of record on Friday, July 22nd will be issued a dividend of $0.03 per share. This represents a dividend yield of 0.03%. The ex-dividend date is Wednesday, July 20th.

In other news, CEO Robert S. Weiss sold 151,839 shares of The Cooper Cos. stock in a transaction on Monday, June 27th. The shares were sold at an average price of $163.02, for a total transaction of $24,752,793.78. Following the completion of the sale, the chief executive officer now directly owns 200,617 shares of the company’s stock, valued at approximately $32,704,583.34. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Stanley Md Zinberg sold 10,000 shares of The Cooper Cos. stock in a transaction on Wednesday, June 29th. The stock was sold at an average price of $170.00, for a total transaction of $1,700,000.00. Following the sale, the director now directly owns 899 shares of the company’s stock, valued at $152,830. The disclosure for this sale can be found here.

Several hedge funds recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in The Cooper Cos. by 3.3% in the fourth quarter. Vanguard Group Inc. now owns 3,465,672 shares of the medical device company’s stock worth $465,092,000 after buying an additional 109,280 shares in the last quarter. Mizuho Trust & Banking Co. Ltd. boosted its position in shares of The Cooper Cos. by 13.5% in the fourth quarter. Mizuho Trust & Banking Co. Ltd. now owns 79,274 shares of the medical device company’s stock worth $10,740,000 after buying an additional 9,454 shares during the last quarter. Gulf International Bank UK Ltd boosted its position in shares of The Cooper Cos. by 3.6% in the fourth quarter. Gulf International Bank UK Ltd now owns 14,531 shares of the medical device company’s stock worth $1,950,000 after buying an additional 500 shares during the last quarter. Principal Financial Group Inc. boosted its position in shares of The Cooper Cos. by 2.7% in the fourth quarter. Principal Financial Group Inc. now owns 154,051 shares of the medical device company’s stock worth $20,674,000 after buying an additional 4,043 shares during the last quarter. Finally, Schroder Investment Management Group boosted its position in shares of The Cooper Cos. by 13.1% in the fourth quarter. Schroder Investment Management Group now owns 307,100 shares of the medical device company’s stock worth $41,213,000 after buying an additional 35,600 shares during the last quarter.

The Cooper Companies, Inc (Cooper) is a medical device company. The Company operates through two business units: CooperVision, Inc (CooperVision) and CooperSurgical, Inc (CooperSurgical). CooperVision develops, manufactures and markets a range of soft contact lenses for the vision correction market. CooperVision offers Biofinity monthly spherical, toric and multifocal lenses under the Avaira brand.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.